Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI)

Molecular Immunology

Volumn 45, Issue 16, 2008, Pages 4080-4083

  Leung, Lawrence L K ^a   Myles, Timothy ^a   Nishimura, Toshihiko ^b   Song, Jason J ^a   Robinson, William H ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cpb; Inflammation; Procpb; Tafi; Thrombin; Thrombin activatable fibrinolysis inhibitor; Thrombin activatable procarboxypeptidase B; Thrombin thrombomodulin

Indexed keywords

CARBOXYPEPTIDASE B; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOMODULIN;

ANIMAL; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; INFLAMMATION; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

ANIMALS; CARBOXYPEPTIDASE B; CARBOXYPEPTIDASE U; INFLAMMATION; MICE; MODELS, IMMUNOLOGICAL; THROMBIN; THROMBOMODULIN;

EID: 55949084990     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.07.010     Document Type: Review

References (19)

1. Bajzar, L., Morser, J., Nesheim, M., 1996. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271, 16603-16608.
2. Bernard, G.R., Vincent, J.L., Laterre, P.F., LaRosa, S.P., et al., 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699-709.
3. Broze, G., Higuchi, D.A., 1996. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots fromhemophilic plasma. Blood 88, 3815-3823.
4. Campbell, W.D., Lazoura, E., Okada, N., Okada, H., 2002. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 46, 131-134.
5. Carter, W.J., Myles, T., Gibbs, C.S., Leung, L.L., Huntington, J.A., 2004. Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery. J. Biol. Chem. 279, 26387-26394.
6. Clark, A., Weymann, A., Hartman, E., Turmelle, Y., Carroll, M., Thurman, J.M., Holers, V.M., Hourcade, D.E., Rudnick, D.A., 2008. Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol. Immunol. 45, 3125-3132.
7. Coughlin, S.R., 2005. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3, 1800-1814.
8. Esmon, C.T., 2003. The protein C pathway. Chest 124, 26S-32S.
9. Esmon, C.T., 2005. The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417-430.
10. Gibbs, C.S., Coutre, S.E., Tsiang, M., Li, W.X., Jain, A.K., Dunn, K.E., Law, V.S., Mao, C.T., Matsumura, S.Y., Mejsa, S.J., Paborsky, L.R., Leung, L.L.K., 1995. Conversion of thrombin into an anticoagulant by protein engineering. Nature 378, 413-416.
11. Huber-Lang, M., Sarma, J.V., Zetoune, F.S., Rittirsch, D., Neff, T.A., McGuire, S.R., Lambris, J.D., Warner, R.L., Flierl, M.A., Hoesel, L.M., Gebhard, F., Younger, J.G., Drouin, S.M., Wetsel, R.A., Ward, P.A., 2006. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12, 682-687.
12. Leung, L.L.K., Gibbs, C.S., 1997. Modulation of thrombin's procoagulant and anticoagulant properties. Thromb. Haemost. 78, 577-580.
13. Myles, T., Nishimura, T., Yun, T.H., Nagashima, M., Morser, J., Patterson, A.J., Pearl, R.G., Leung, L.L.K., 2003. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J. Biol. Chem. 278, 51059-51067.
14. Myles, T., Leung, L.L.K., 2008. Thrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites. J. Biol. Chem. 283, 17789-17796.
15. Nishimura, T., Myles, T., Piloponsky, P., Kao, P., Berry, G.J., Leung, L.L.K., 2007. Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo. Blood 109, 1992-1997.
16. Redlitz, A., Tan, A.K., Eaton, D.L., Plow, E.F., 1995. Plasma carboxypeptidases as regulators of the plasminogen system. J. Clin. Invest. 96, 2534-2538.
17. Shinohara, T., Sakurada, C., Suzuki, T., Takeuchi, O., Campbell, W., Ikeda, S., Okada, N., Okasda, H., 1994. Pro-carboxypeptidase R cleaves bradykinin following activation. Int. Arch. Allergy Immunol. 103, 400-404.
18. Song, J., Nishimura, T., Garcia, M., Myles, T., Ho, P., Du, X.Y., Sharif, S., Leung, L., Robinson, W., 2007. Thrombin-activatable carboxypeptidase B prevents anti-collagen antibody induced arthritis. Clin. Immunol. 123 (Suppl.), S98.
19. Tsiang, M., Paborsky, L.R., Li, W.X., Jain, A.K., Mao, C.T., Dunn, K.E., Lee, D.W., Matsumura, S.Y., Matteucci, M.D., Coutre, S.E., Leung, L.L.K., Gibbs, C.S., 1996. Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo. Biochemistry 35, 16449-16457.